Richard Aranda's Insider Trades & SAST Disclosures
Richard Aranda's most recent trade in Gossamer Bio Inc was a trade of 572,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 4, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Richard Aranda.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 572,000 | 572,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.66 per share. | 24 Jun 2024 | 1,908 | 196,891 (0%) | 0% | 0.7 | 1,260 | Common Stock |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.33 per share. | 18 Mar 2024 | 4,018 | 198,799 (0%) | 0% | 1.3 | 5,342 | Common Stock |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 487,500 | 487,500 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.29 per share. | 22 Jun 2023 | 1,814 | 197,574 (0%) | 0% | 1.3 | 2,340 | Common Stock |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 190,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 126,667 | 126,667 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 60,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 45,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 34,175 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 30,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 22,784 | 22,784 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 13,750 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 9,167 | 9,167 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2023 | 157,500 | 157,500 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.10 per share. | 16 Mar 2023 | 7,563 | 199,388 (0%) | 0% | 1.1 | 8,304 | Common Stock |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.07 per share. | 24 Oct 2022 | 4,757 | 205,430 (0%) | 0% | 12.1 | 57,431 | Common Stock |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.88 per share. | 22 Jun 2022 | 1,778 | 209,897 (0%) | 0% | 6.9 | 12,233 | Common Stock |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.28 per share. | 16 Mar 2022 | 6,278 | 211,675 (0%) | 0% | 8.3 | 51,976 | Common Stock |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 190,000 | 190,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.25 per share. | 25 Oct 2021 | 2,377 | 217,432 (0%) | 0% | 12.2 | 29,118 | Common Stock |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2021 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2021 | 15,000 | 219,809 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges